These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2296881)

  • 1. Results of high dose intravenous urokinase for acute myocardial infarction.
    Wall TC; Phillips HR; Stack RS; Mantell S; Aronson L; Boswick J; Sigmon K; DiMeo M; Chaplin D; Whitcomb D
    Am J Cardiol; 1990 Jan; 65(3):124-31. PubMed ID: 2296881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.
    Califf RM; Topol EJ; Stack RS; Ellis SG; George BS; Kereiakes DJ; Samaha JK; Worley SJ; Anderson JL; Harrelson-Woodlief L
    Circulation; 1991 May; 83(5):1543-56. PubMed ID: 1902405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group.
    Lincoff AM; Topol EJ; Califf RM; Sigmon KN; Lee KL; Ohman EM; Rosenschein U; Ellis SG
    Am J Cardiol; 1995 May; 75(14):871-6. PubMed ID: 7732992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.
    Topol EJ; Califf RM; George BS; Kereiakes DJ; Rothbaum D; Candela RJ; Abbotsmith CW; Pinkerton CA; Stump DC; Collen D
    Circulation; 1988 May; 77(5):1100-7. PubMed ID: 2966017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new thrombolytic regimen for acute myocardial infarction using combination half dose tissue-type plasminogen activator with full dose streptokinase: a pilot study. KAMIT Study Group.
    Grines CL; Nissen SE; Booth DC; Branco MC; Gurley JC; Bennett KA; DeMaria AN
    J Am Coll Cardiol; 1989 Sep; 14(3):573-80. PubMed ID: 2504797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thrombolytic regimen, early catheterization, and predischarge angiographic variables on six-week left ventricular function. The TAMI Investigators. Thrombolysis and Angioplasty in Acute Myocardial Infarction.
    Ward SR; Sutton JM; Pieper KS; Schwaiger M; Califf RM; Topol EJ
    Am J Cardiol; 1997 Mar; 79(5):539-44. PubMed ID: 9068505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase.
    Morris JA; Muller DW; Topol EJ
    Am Heart J; 1991 Aug; 122(2):375-80. PubMed ID: 1907086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS).
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    J Am Coll Cardiol; 1988 Sep; 12(3):581-7. PubMed ID: 3042835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty.
    Abbottsmith CW; Topol EJ; George BS; Stack RS; Kereiakes DJ; Candela RJ; Anderson LC; Harrelson-Woodlief SL; Califf RM
    J Am Coll Cardiol; 1990 Oct; 16(4):770-8. PubMed ID: 1698843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous transluminal coronary angioplasty, alone or in combination with urokinase therapy, during acute myocardial infarction.
    Oshima S; Saito T; Nakamura S; Noda K; Date H; Hokimoto S; Taniguchi I; Yamamoto N
    Jpn Circ J; 1999 Feb; 63(2):91-6. PubMed ID: 10084370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.
    Ohman EM; Califf RM; Topol EJ; Candela R; Abbottsmith C; Ellis S; Sigmon KN; Kereiakes D; George B; Stack R
    Circulation; 1990 Sep; 82(3):781-91. PubMed ID: 2394002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of extended urokinase infusion plus stent deployment for treatment of obstructed, older saphenous vein grafts.
    Denardo SJ; Morris NB; Rocha-Singh KJ; Curtis GP; Rubenson DS; Teirstein PS
    Am J Cardiol; 1995 Oct; 76(11):776-80. PubMed ID: 7572653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated plasminogen activator dose regimens for coronary thrombolysis. The TAMI-7 Study Group.
    Wall TC; Califf RM; George BS; Ellis SG; Samaha JK; Kereiakes DJ; Worley SJ; Sigmon K; Topol EJ
    J Am Coll Cardiol; 1992 Mar; 19(3):482-9. PubMed ID: 1537998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous urokinase in acute myocardial infarction.
    Mathey DG; Schofer J; Sheehan FH; Becher H; Tilsner V; Dodge HT
    Am J Cardiol; 1985 Apr; 55(8):878-82. PubMed ID: 3984876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction. TAMI-5 Study Group.
    Muller DW; Topol EJ; Ellis SG; Woodlief LH; Sigmon KN; Kereiakes DJ; George BS; Worley SJ; Samaha JK; Phillips H
    J Am Coll Cardiol; 1991 Dec; 18(7):1594-601. PubMed ID: 1960302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous infusion of recombinant tissue-type plasminogen activator (rt-PA) and urokinase in acute myocardial infarct: intermediate results of the G.A.U.S. study (German Activator Urokinase Study)].
    Neuhaus KL; Tebbe U; Gottwik M; Weber MA; Feuerer W; Niederer W; Haerer W; Praetorius F; Grosser KD; Huhmann W
    Klin Wochenschr; 1988; 66 Suppl 12():102-8. PubMed ID: 3126339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study.
    Verheugt FW; Liem A; Zijlstra F; Marsh RC; Veen G; Bronzwaer JG
    J Am Coll Cardiol; 1998 Feb; 31(2):289-93. PubMed ID: 9462569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of segmental kinetics of the left ventricle after intravenous administration of urokinase in the acute phase of myocardial infarction].
    Garnier LF; François G; Charbonnier B; Lang M; Raynaud P; Brochier M
    Ann Cardiol Angeiol (Paris); 1987 Jun; 36(6):313-7. PubMed ID: 3619386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intracoronary and intravenous urokinase in acute myocardial infarction.
    Cernigliaro C; Sansa M; Campi A; Bongo AS; Carfora A; Rossi P
    G Ital Cardiol; 1984 Nov; 14(11):927-30. PubMed ID: 6526208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recanalization of Chronically Occluded Aortocoronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion of Urokinase (ROBUST): a serial trial.
    Hartmann JR; McKeever LS; O'Neill WW; White CJ; Whitlow PL; Gilmore PS; Doorey AJ; Galichia JP; Enger EL
    J Am Coll Cardiol; 1996 Jan; 27(1):60-6. PubMed ID: 8522711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.